Background: Preservative assay in eye drops require the development of a suitable validated method for the assay.
Introduction
Benzalkonium chloride is a mixture of alkyl benzyl dimethyl ammonium chlorides of the general formula [C 6 H 5 CH 2 N(CH3) 2 R]Cl, where R represents a mixture of alkyls, including all or some of the group beginning with n-C 8 H 17 and extending through higher homologs, with n-C 12 H 25 , n-C14H 29 , and n-C 16 H 33 comprising the major portion. The average molecular weight of benzalkonium chloride is 360.The chemical structure is shown in Figure 1 . Benzalkonium chloride is used in pharmaceutical formulations as antimicrobial and in eye drops as a preservative at a concentration of 0.01-0.02% w/v [1] [2] [3] [4] [5] . Often it is used in combination with other preservatives or excipients, particularly 0.1% w/v disodium edetate, to enhance its antimicrobial activity against strains of Pseudomonas. In addition to this, it is used as a preservative in cosmetics [6, 7] . Betaxolol hydrochloride is a white, crystalline powder, soluble in water, with a molecular weight of 343.89. The chemical structure is present in Figure 2 . Betaxolol chloride in ophthalmic preparations has been shown to be effective in lowering intraocular pressure and is indicated in the treatment of ocular hypertension and chronic open-angle glaucoma [8, 9] . It may be used alone or in combination with other anti-glaucoma. Numerous authors described the determination of benzalkonium chloride in pharmaceutical ophthalmic preparations by using high performance liquid chromatography, HPLC/MS, capillary electrophoresis and TLC densitometry but most of their work focused on HPLC [10] [11] [12] [13] [14] [15] . In this work we present a simple robust, accurate and precise method for the determination of benzalkonium chloride in betaxolol (0.5%) ophthalmic solutions.
Materials and Methods

Chemicals
Benzalkonium chloride working standard (100% purity) obtained from Merck, Germany. Acetonitrile and glacial acetic acid (HPLC Grade, SDFCL). Sodium acetate, disodium edetate sodium chloride (Charlo Erba) Purified water is. Ltd. Betxalol standard (99% purity) and betaxolol 0.5% ophthalmic solution samples. Obtained from Bash Pharma, Co Sudan. 
Instruments
Liquid chromatographic conditions
Injection volume 100 µL, flow rate; 2.0 mL/ minute, detection wavelength of 254 nm;column oven 30°C mobile phase (0.1M sodium acetate, acetonitrile (55:45 v/v).
Methods
Mobile phase preparation:
Exactly 0.1M Sodium acetate buffer powder was prepared and the pH was adjusted to 5.00 with glacial acetic Acid. The mobile phase was prepared by mixing 0.1 M sodium acetate buffer and acetonitrile (45% 55%, v/v). The mixture was filtered and degassed for 10 minutes by sonication.
Benzalkonium chloride standard stock solution:
Exactly 100 mg of benzalkonium chloride standard were accurately weighed and transferred into a 100 ml volumetric flask; the volume was completed up to mark using purified water and sonicated for 1 minute to produce a solution having a concentration of 1000 µg/ml.
Preparation of placebo solution:
The solution containing betaxolol excipients (disodium edetate sodium chloride) excluding benzalkonium chloride is used as placebo.
Results and Discussion
System suitability test
A stock solution of benzalkonium chloride of a concentration of 200 µg/ml was prepared and was injected five times and the results obtained are shown in Table 1 and the obtained chromatogram is shown in Figure 3 . 
Injection
Stability of solution
A benzalkonium chloride solution (200ug/ml) was injected into HPLC system as fresh sample. and then was injected after 6 hours and after 24 hours. A fresh test solution was prepared and analysed after six hours and 24 hours. At each time, the sample was analyzed five times. Interady RSD% were 0.19, 33 and 33%. RSD% of sum peaks area of fresh injected working standard of benzalkonium chloride, after 6 hours and after 24 hours was calculated and found to be 0.28%.
Linearity
A series of seven concentrating levels (100. 
Limit of detection and limit of quantification
The limit of detection (LOD) and the limit of quantification (LOQ) of the benzalkonium chloride were calculated according to ICH guidelines. The values obtained were 4.53 µg/ml and 13.75 µg/ml, respectively.
Specificity
Placebo of the betaxolol (0.5%) ophthalmic solution, equivalent to the sample volume was taken and solution prepared and analysed. No interferents peaks were shown in the obtained chromatogram.
Accuracy
Three different quantities (low, medium and high i.e. 80%, 100% and 130% of the standard test solution) of the authentic standard were prepared and injected in triplicate for each spike level. The results obtained were acceptable (acceptance recovery criteria % is 98%-102 %). See Table 2 . Table 2 : Results of the recovery study.
Conc
Precision
Study of the precision of the assay was determined by repeatability (intra-day) and intermediate precision (inter-day) in triplicate. Repeatability was evaluated by assaying of eight determinations at 100% of the test concentrations.
Intermediate precision was assessed by comparing the assay of eight determinations at 100% of the test concentrations on different days (3 days) prepared in the same manner for repeatability. The RSD% obtained was <2.
Intra-day precision:
Day 1 Table 3 : Benzalkonium chloride results of the intra-day precision test (repeatability).
Intermediate precision:
The overall intermediate precision of the method is shown in 
Robustness
The Robustness was determined by injecting triplicate injections of standard solution. The parameters tested were, flow rate, column oven temperature and detection wavelength mobile phase pH. A summary of Robustness Parameters is given in Table 5 .
Flow rate
Flow rate 1. 
Forced degradation studies
Forced degradation was studied by a deliberate degradation through exposure of betaxolol eye drops 0.5% to acid hydrolysis, base hydrolysis, photo degradation (UV, 254nm), heat and oxidation as follows; 5 ml of betaxolol eye drops solution was transferred to 100-ml volumetric flask; 5 ml of 1M HCl was added, mixed and allowed to stand for 60 minutes at room temperature. The volume was completed up to mark using placebo and sonicated for 1 minute, the solution mixed, filtered and injected into the HPLC system. The same procedure was repeated with the addition of 5 ml of 0.01M NaOH for base hydrolysis, or 5 ml of 30% H 2 O 2 (oxidation) or exposure to UV radiation for photo-degradation study.
For the effect of heat study, 5 ml of betaxolol 0.5% ophthalmic solution was transferred to 100-ml volumetric flask and exposed for dry heat (oven) at 25, 35, 45, 55 and 65°C. Then the volume was completed up to mark using placebo and sonicated for 1 minute, mixed, filtered and injected into the HPLC system. The assay of the drug was 99.32%. The results of the drug assay after subjection the drug to the above mentioned stress conditions are shown in Table 6 . 
Stress condition
Conclusion
A simple, sensitive, cost-effective method for the determination of benzalkonium chloride in betaxolol 0.5%
